advertisement
Pfeiffer N 14
Showing records 1 to 14 | Display all abstracts from Pfeiffer N106321 Dynamin-like Protein 1 (DNML1) as a Molecular Target for Antibody-Based Immunotherapy to Treat Glaucoma
Tonner H
International journal of molecular sciences 2022; 23:
106224 Synthetic antibody-derived immunopeptide provides neuroprotection in glaucoma through molecular interaction with retinal protein histone H3.1
Fomo KN
Frontiers in medicine 2022; 9: 993351
106318 Short-Term Omega-3 Supplementation Modulates Novel Neurovascular and Fatty Acid Metabolic Proteome Changes in the Retina and Ophthalmic Artery of Mice with Targeted Gene Deletion
Perumal N
Cells 2022; 11:
106224 Synthetic antibody-derived immunopeptide provides neuroprotection in glaucoma through molecular interaction with retinal protein histone H3.1
Schmelter C
Frontiers in medicine 2022; 9: 993351
106321 Dynamin-like Protein 1 (DNML1) as a Molecular Target for Antibody-Based Immunotherapy to Treat Glaucoma
Hunn S
International journal of molecular sciences 2022; 23:
106318 Short-Term Omega-3 Supplementation Modulates Novel Neurovascular and Fatty Acid Metabolic Proteome Changes in the Retina and Ophthalmic Artery of Mice with Targeted Gene Deletion
Herfurth A
Cells 2022; 11:
106224 Synthetic antibody-derived immunopeptide provides neuroprotection in glaucoma through molecular interaction with retinal protein histone H3.1
Atta J
Frontiers in medicine 2022; 9: 993351
106321 Dynamin-like Protein 1 (DNML1) as a Molecular Target for Antibody-Based Immunotherapy to Treat Glaucoma
Auler N
International journal of molecular sciences 2022; 23:
106318 Short-Term Omega-3 Supplementation Modulates Novel Neurovascular and Fatty Acid Metabolic Proteome Changes in the Retina and Ophthalmic Artery of Mice with Targeted Gene Deletion
Pfeiffer N; Manicam C
Cells 2022; 11:
106224 Synthetic antibody-derived immunopeptide provides neuroprotection in glaucoma through molecular interaction with retinal protein histone H3.1
Beutgen VM
Frontiers in medicine 2022; 9: 993351
106321 Dynamin-like Protein 1 (DNML1) as a Molecular Target for Antibody-Based Immunotherapy to Treat Glaucoma
Schmelter C; Pfeiffer N
International journal of molecular sciences 2022; 23:
106224 Synthetic antibody-derived immunopeptide provides neuroprotection in glaucoma through molecular interaction with retinal protein histone H3.1
Schwarz R; Perumal N
Frontiers in medicine 2022; 9: 993351
106321 Dynamin-like Protein 1 (DNML1) as a Molecular Target for Antibody-Based Immunotherapy to Treat Glaucoma
Grus FH
International journal of molecular sciences 2022; 23:
106224 Synthetic antibody-derived immunopeptide provides neuroprotection in glaucoma through molecular interaction with retinal protein histone H3.1
Govind G; Speck T; Pfeiffer N; Grus FH
Frontiers in medicine 2022; 9: 993351
